Intranasal zavegepant is moderately superior to placebo for acute migraine in adults

Question clinique

Is intranasal zavegepant effective in relieving acute migraine attacks in adults?

L’Essentiel

In this large study, the newly approved intranasal zavegepant was moderately superior to placebo in helping adults with acute migraine become pain free within 2 hours of treatment. 1b

Plan de l'etude: Randomized controlled trial (double-blinded)

Financement: Industry

Cadre: Outpatient (specialty)

Reviewer

Henry C. Barry, MD, MS
Professor
Michigan State University
East Lansing, MI


Discutez de ce POEM


Commentaires

Anonymous

Savegepant - Migraine

Moderately superior - to placebo! And comparatively to intranasal triptans et al?

ARUP KUMAR DHARA

Impact assessment

Excellent

Anonymous

acute migraine relief

intranasal zavegepant